Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Dementia l: Introduction01:22

Dementia l: Introduction

35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fatigue relief is possible.

Frontiers in integrative neuroscience·2026
Same author

A spectral- topological network signature of drug-resistant epilepsy: a phase 1-2 study on resting-state EEG-based diagnostic biomarkers of drug resistance.

NeuroImage. Clinical·2026
Same author

Fatigue relief: the contribution of non-invasive neuromodulation (FAREviaNM).

Frontiers in neuroscience·2026
Same author

Altered neural avalanche spreading in people with drug-resistant epilepsy<sup>✰</sup>.

NeuroImage·2025
Same author

Editorial: Amplifying Efficiency and Accuracy in Dementia Drug Development.

The journal of prevention of Alzheimer's disease·2024
Same author

Quantitative measures of the resting EEG in stroke: a systematic review on clinical correlation and prognostic value.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2023

Related Experiment Video

Updated: May 4, 2026

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice
07:03

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Published on: July 31, 2019

6.4K

Sensorimotor Cortex Reorganization in Alzheimer's Disease and Metal Dysfunction: A MEG Study.

C Salustri1, F Tecchio2, F Zappasodi3

  • 1Institute of Cognitive Sciences and Technologies (CNR), Unità MEG, Fatebenefratelli Hospital, Isola Tiberina, 00186 Rome, Italy.

International Journal of Alzheimer'S Disease
|January 14, 2014
PubMed
Summary

Systemic non-ceruloplasmin copper, not total copper, impacts brain neurotransmission in Alzheimer's disease (AD) patients. Early-stage AD shows greater neuronal reorganization, suggesting physical and cognitive activities may be protective.

More Related Videos

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

1.5K
Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

1.3K

Related Experiment Videos

Last Updated: May 4, 2026

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice
07:03

Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice

Published on: July 31, 2019

6.4K
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

1.5K
Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

1.3K

Area of Science:

  • Neuroscience
  • Biometals Research
  • Alzheimer's Disease Pathophysiology

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline.
  • Systemic biometal dysfunctions, particularly copper imbalances, are implicated in AD pathogenesis.
  • The precise role of specific copper fractions in AD-related neurotransmission deficits remains unclear.

Purpose of the Study:

  • To investigate the association between systemic biometal levels and neurotransmission in living Alzheimer's disease patients.
  • To assess the neuroplasticity of the primary somatosensory cortex in response to disease progression.
  • To determine if specific copper fractions, rather than total copper, correlate with altered sensorimotor processing in AD.

Main Methods:

  • A case-control study utilizing magnetoencephalography (MEG) to analyze sensorimotor fields in AD patients and controls.
  • Assessment of neuronal activation patterns in the primary somatosensory cortex during median nerve stimulation.
  • Quantification of systemic levels of copper, ceruloplasmin, non-ceruloplasmin (non-Cp) copper, peroxides, transferrin, and total antioxidant capacity.

Main Results:

  • AD patients exhibited spatially shifted sensorimotor generators without changes in latency or strength.
  • Greater neuronal reorganization was observed in moderately ill AD patients, while severe AD patients showed increased delta activity.
  • Systemic non-Cp copper levels were significantly associated with sensorimotor transmission alterations in AD patients.

Conclusions:

  • Non-ceruloplasmin copper, specifically, influences neuronal activity and sensorimotor transmission in Alzheimer's disease.
  • The findings suggest that early-stage AD exhibits significant neuroplasticity, potentially influenced by environmental factors.
  • Physical and cognitive activities may serve as protective factors against AD progression due to their potential to enhance neuroplasticity.